Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma-Reference-Cited by-同舟云学术

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma

Published:2014 Issue:1 Volume:15 Page:190
ISSN:1471-2164
Container-title:BMC Genomics
language:en
Short-container-title:BMC Genomics

Author:

Castle John C,Loewer Martin,Boegel Sebastian,de Graaf Jos,Bender Christian,Tadmor Arbel D,Boisguerin Valesca,Bukur Thomas,Sorn Patrick,Paret Claudia,Diken Mustafa,Kreiter Sebastian,Türeci Özlem,Sahin Ugur

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biotechnology

Reference45 articles.

1. KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer

2. A Selective Small Molecule c-MET Inhibitor, PHA665752, Cooperates with Rapamycin

3. Targeting transforming growth factor-β signaling in liver metastasis of colon cancer

4. Single-cell dissection of transcriptional heterogeneity in human colon tumors

5. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

Cited by 298 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-assembly nanoparticles potentiate in-situ tumor vaccine of radiotherapy by regulating tumor immunogenicity and tumor-associated macrophages;Chemical Engineering Journal;2024-10

2. Synthesis, Photo-Characterizations, and Pre-Clinical Studies on Advanced Cellular and Animal Models of Zinc(II) and Platinum(II) Sulfonyl-Substituted Phthalocyanines for Enhanced Vascular-Targeted Photodynamic Therapy;ACS Applied Materials & Interfaces;2024-09-06

3. Mitochondrial rewiring with small-molecule drug-free nanoassemblies unleashes anticancer immunity;Nature Communications;2024-09-03

4. Metabolite-based inter-kingdom communication controls intestinal tissue recovery following chemotherapeutic injury;Cell Host & Microbe;2024-09

5. Altered epitopes enhance macrophage‐mediated anti‐tumour immunity to low‐immunogenic tumour mutations;Immunology;2024-08-22